The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
Open accessAbstract
Background: Androgenetic alopecia (AGA) is the most common form of hair loss consisting of a characteristic receding frontal hairline in men and diffuse hair thinning in women, with frontal hairline retention, and can impact an individual's quality of life. The condition is primarily mediated by 5‐alpha‐reductase and dihydrotestosterone (DHT) which causes hair follicles to undergo miniaturization and shortening of successive anagen cycles. Although a variety of medical, surgical, light‐based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select appropriate therapies for this chronic condition. Aims: To highlight treatment options for androgenetic alopecia taking into consideration the efficacy, side effect profiles, practicality of treatment (compliance), and costs to help clinicians offer ethically appropriate treatment regimens to their patients. Materials and Methods: A literature search was conducted using electronic databases (Medline, PubMed, Embase, CINAHL, EBSCO) and textbooks, in addition to the authors' and other practitioners' clinical experiences in treating androgenetic alopecia, and the findings are presented here. Results: Although topical minoxidil, oral finasteride, and low‐level light therapy are the only FDA‐approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation. Discussion: Androgenetic alopecia therapy remains challenging as treatment selection involves ethical, evidence‐based decision‐making and consideration of each individual patient's needs, compliance, budget, extent of hair loss, and aesthetic goals, independent of potential financial benefits to the practitioners.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Organic Causes of Erectile Dysfunction in Men Under 40
Ludwig, W., & Phillips, M. (2014) · Urologia Internationalis · doi:10.1159/000354931 · Cited by 2,156
The Nuts and Bolts of Low-level Laser (Light) Therapy
Chung, H., Dai, T., Sharma, S. K., Huang, Y.-Y., Carroll, J. D., & Hamblin, M. R. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0454-7 · Cited by 1,624
Ha, D. H., Kim, H.-K., Lee, J., Kwon, H. H., Park, G.-H., Yang, S. H., Jung, J. Y., Choi, H., Lee, J. H., Sung, S., et al. (2020) · Cells · doi:10.3390/cells9051157 · Cited by 539
Androgenetic alopecia: a review
Lolli, F., Pallotti, F., Rossi, A., Fortuna, M. C., Caro, G., Lenzi, A., Sansone, A., & Lombardo, F. (2017) · Endocrine · doi:10.1007/s12020-017-1280-y · Cited by 533
Eells, J. T., Wong-Riley, M. T. T., VerHoeve, J., Henry, M., Buchman, E. V., Kane, M. P., Gould, L. J., Das, R., Jett, M., & Hodgson, B. D. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.033 · Cited by 476
Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030330 · Cited by 467
Minoxidil and its use in hair disorders: a review
Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019) · Drug Design, Development and Therapy · doi:10.2147/dddt.s214907 · Cited by 451
Olsen, E. A., Dunlap, F. E., Funicella, T., Koperski, J. A., Swinehart, J. M., Tschen, E. H., & Trancik, R. J. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.124088 · Cited by 437
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
Adil, A., & Godwin, M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.02.054 · Cited by 423
Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm
Yin, K., Wang, S., & Zhao, R. C. (2019) · Biomarker Research · doi:10.1186/s40364-019-0159-x · Cited by 380
Metadata
- Authors
- Nestor, M. S., Ablon, G., Gade, A., Han, H., & Fischer, D. L.
- Venue
- Journal of Cosmetic Dermatology
- Publisher
- Wiley
- Published
- 2021-11-06
- Volume
- 20
- Issue
- 12
- Pages
- 3759-3781
- ISSN
- 1473-2130 (ISSN-L)
- 1473-2165
- OpenAlex
- W3210217088
- Cited by
- 410
- References
- 108
- FWCI
- 49.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. https://app.cochat.ai/papers/10.1111/jocd.14537
- The paper
- Nestor, M. S., Ablon, G., Gade, A., Han, H., & Fischer, D. L. (2021). Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.14537
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.